Sunday, November 1, 2026

Son Heung-min Aims to Score: Can LA FC Turn the Tide Against Colorado Rapids?

Son Heung-min of LA FC aims to score against Colorado Rapids in his first start in five matches.

Samsung SDI-Powered Lucid Air GT Sets World Record for Longest EV Range

Lucid Motors' Lucid Air GT sets a world record for EV range with Samsung SDI's cylindrical batteries, achieving 1,205 km on a single charge.

KAIST Develops Advanced Quadrupedal Robot with Self-Adaptive Walking Skills for Outdoor Environments

KAIST's Professor Park Hae-won reveals a new control tech for quadrupedal robots, enabling versatile locomotion in diverse terrains.

Health

Unlock Your Health: Discover the New AI-Powered BioAge and Health Coach Services from DaNaA Data

Daewoo Group's AI health data firm, DaNaA Data, launched a service analyzing biological age, disease risk, and health check results.

How the New Medical School in Namwon Can Transform Regional Healthcare: Insights from Lawmaker Park Ji-won

Defining school locations alone won't solve local healthcare issues; deeper strategies are needed for effective solutions.

Ardens Lifescience Triumphs: How a Korean Startup Won 175,000 USD at MedTech Innovator APAC 2026

Adenz Life Sciences wins a global medical device competition, earning a prize of 175,000 USD.

Unlocking the Future of Healthcare: Daewoong’s AI-Powered Smart Hospital at AI EXPO MARS 2026

Daewoong Pharmaceutical introduces an AI-based smart hospital model for monitoring, diagnosis, testing, and rehabilitation.

10 Years of Excellence: Seoul’s APLAR Center Hosts International Rheumatology Training for Young Specialists

Seoul St. Mary's Hospital's Rheumatology Center held an international training program for foreign experts on October 27 and 26.
Latest

Unlocking Cell Growth: How LARS1 Protein Transforms Nutritional Signals into Cancer Treatment Insights

KAIST researchers unveil how cells sense nutrients, linking it to mTORC1 activation, paving the way for targeted cancer therapies.

HyDIFFUZE™: The Game-Changer in Subcutaneous ADC Delivery for Cancer Treatment

Huons Lab patents a platform technology for ADC subcutaneous injections, enhancing stability and drug delivery efficiency in biopharmaceuticals.

Unlocking the Future of Robotic-Assisted Surgery: Insights from Intuitive 360 Korea 2026

Intuitive Surgical Korea hosted the Intuitive 360 Korea 2026 event, discussing the future of robotic-assisted surgery and digital transformation.

Radiopharmaceuticals Revolution: How Novartis’s 1.4 Billion USD Investment Transforms Cancer Treatment in South Korea

A 140 billion KRW investment by Novartis aims to enhance the radioactive pharmaceutical industry, focusing on precision medicine and Theranostics.

Depression Linked to Up to 2.4-Fold Higher Risk of Fatty Liver Disease in Young Adults, Study Finds

A South Korean study reveals young adults with depression face double the risk of fatty liver disease compared to those without.

Cancer Patients Say Long Waits, Limited Consultation Time Leave Questions Unanswered

A study reveals cancer patients face communication barriers, emotional distress, and lack of support during treatment, necessitating better care.

HLB PEP Achieves FDA Registration for Vasopressin API: What This Means for Global Markets

HLB PEP has registered Vasopressin API with the FDA, aiming for global market entry and expanding its peptide portfolio.

EuBiologics Registers EcML Adjuvant Platform With U.S. FDA Drug Master File

EuBiologics' EcML™ vaccine adjuvant platform has been registered with the FDA, enhancing immunogenicity and enabling global collaborations.

Celltrion Files for European Approval of Cosentyx Biosimilar, Targets $6.7 Billion Market

Celltrion has filed for European approval of its CT-P55 biosimilar for autoimmune diseases, aiming for early market entry and expansion.

Unlocking Precision Medicine: New Antibody Design Targets KRAS(G12D) in Cancer Cells

Researchers at KAIST developed an antibody targeting KRAS(G12D) mutation, revolutionizing cancer treatment with precise immunotherapy.

Eli Lilly’s Retatrutide: The Revolutionary Triple Hormone Treatment for Obesity – What You Need to Know

Eli Lilly's retatrutide shows promising results in Phase 3 trials, aiming for FDA approval for obesity and related conditions in 2027.

How Hanmi Pharmaceutical’s AI Platform is Revolutionizing Obesity Drug Development in 2026

Hanmi Pharmaceutical leverages AI for drug discovery, developing innovative obesity treatments and advancing to clinical trials.

Interview | “Suicides Are Falling Overall? Not Among Young People—We Need Policies That Look 20 Years Ahead”

The government's suicide prevention efforts show a decline in overall rates, but youth suicides remain a critical issue needing attention.

Blood Test Alone May Predict Chemotherapy Response and Prognosis in Lymphoma Patients

South Korean researchers discover a mechanism reducing rituximab's effectiveness in DLBCL and propose a predictive blood biomarker.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.